Ubs Oconnor LLC Tandem Diabetes Care Inc Transaction History

Ubs Oconnor LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $202,115 - $319,774	-5,695 Reduced 21.39%	20,935 $0
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $223,176 - $351,747	5,100 Added 23.69%	26,630 $1.27 Billion
Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $646,356 - $1.49 Million	12,145 Added 129.41%	21,530 $1.27 Million
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $956,237 - $1.41 Million	9,385 New	9,385 $1.09 Million

346

70.9M

3.11M

181K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.23B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.